Stock Scorecard



Stock Summary for Petmed Express Inc (PETS) - $1.63 as of 11/26/2025 3:29:18 PM EST

Total Score

13 out of 30

Safety Score

27 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PETS

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PETS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PETS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PETS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PETS (27 out of 100)

Stock Price Rating (Max of 10) 2
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for PETS

PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair 10/20/2025 12:30:00 PM
PETMED REMINDER: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of Stockholders - PetMed Express ( NASDAQ:PETS ) 10/15/2025 9:06:00 PM
PetMeds® Files Form 10-K for Fiscal 2025 10/14/2025 8:15:00 PM
PetMed Express ( PETS ) Faces Investor Scrutiny Amid Filing Delays, Executive Departures, Admitted Accounting Rule Violations -- Hagens Berman - PetMed Express ( NASDAQ:PETS ) 10/9/2025 10:58:00 PM
PETMED INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating PetMed Express, Inc. on Behalf of PetMed Stockholders and Encourages Investors to Contact the Firm - PetMed Express ( NASDAQ:PETS ) 9/8/2025 9:03:00 PM
PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm - PetMed Express ( NASDAQ:PETS ) 8/19/2025 8:35:00 PM
PetMeds Investor ALERT: Block & Leviton Investigating PetMed Express For Securities Fraud; Investors Should Contact the Firm To Potentially Recover Losses - PetMed Express ( NASDAQ:PETS ) 8/18/2025 2:17:00 PM
PetMed Express, Inc. Announces Management Changes - PetMed Express ( NASDAQ:PETS ) 8/12/2025 8:11:00 PM
PetMed Express, Inc. Announces Management Changes 8/12/2025 8:11:00 PM
Fusemachines Appoints Christine Chambers, Experienced Public Company CFO, as Chief Financial Officer 8/8/2025 12:30:00 PM

Financial Details for PETS

Company Overview

Ticker PETS
Company Name Petmed Express Inc
Country USA
Description PetMed Express, Inc. (PETS), operating under the renowned brand 1-800-PetMeds, is a leading online pet pharmacy based in Delray Beach, Florida. The company specializes in a wide array of prescription and non-prescription medications, as well as pet supplies, effectively addressing the diverse needs of pet owners across the United States. With a strong emphasis on affordability, convenience, and customer service, PetMed Express is well-positioned to capitalize on the growing pet care market, aiming to enhance its market share through a strategic focus on quality healthcare solutions for pets. As the demand for accessible pet healthcare continues to rise, the company is committed to delivering exceptional service and expanding its product offerings.
Sector Name HEALTHCARE
Industry Name PHARMACEUTICAL RETAILERS
Most Recent Quarter 9/30/2025
Next Earnings Date 11/26/2025

Stock Price History

Last Day Price 1.63
Price 4 Years Ago 22.53
Last Day Price Updated 11/26/2025 3:29:18 PM EST
Last Day Volume 169,205
Average Daily Volume 173,538
52-Week High 6.85
52-Week Low 1.59
Last Price to 52 Week Low 2.52%

Valuation Measures

Trailing PE N/A
Industry PE N/A
Sector PE 88.38
5-Year Average PE 13.04
Free Cash Flow Ratio 0.63
Industry Free Cash Flow Ratio N/A
Sector Free Cash Flow Ratio 28.18
Current Ratio Most Recent Quarter 1.26
Total Cash Per Share 2.60
Book Value Per Share Most Recent Quarter 4.12
Price to Book Ratio 0.39
Industry Price to Book Ratio N/A
Sector Price to Book Ratio 32.98
Price to Sales Ratio Twelve Trailing Months 0.15
Industry Price to Sales Ratio Twelve Trailing Months N/A
Sector Price to Sales Ratio Twelve Trailing Months 15.65
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 21,015,600
Market Capitalization 34,255,428
Institutional Ownership 35.35%

Dividends

Ex-Dividend Date 8/11/2023
Previous Dividend Amount 0.0000
Current Dividend Amount 0.3000
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 1.22
Forward Annual Dividend Yield 24.13%
5-Year Dividend Payments Count 15
3-Year Average Dividend Yield 9.34%
5-Year Average Dividend Yield 6.70%
1-Year Dividend Growth Rate Percentage 33.33%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 1.97%
All-Time Dividend Growth Rate Percentage 11.34%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 266.70%
Annual Earnings Growth -245.21%
Reported EPS 12 Trailing Months -0.30
Reported EPS Past Year -0.06
Reported EPS Prior Year -0.08
Net Income Twelve Trailing Months -6,271,000
Net Income Past Year -7,464,000
Net Income Prior Year 5,140,000
Quarterly Revenue Growth YOY -22.00%
5-Year Revenue Growth -0.17%
Operating Margin Twelve Trailing Months -27.50%

Balance Sheet

Total Cash Most Recent Quarter 54,720,000
Total Cash Past Year 55,296,000
Total Cash Prior Year 104,086,000
Net Cash Position Most Recent Quarter 54,720,000
Net Cash Position Past Year 55,296,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 96,731,000
Total Stockholder Equity Prior Year 123,795,000
Total Stockholder Equity Most Recent Quarter 85,134,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -395,000
Free Cash Flow Per Share Twelve Trailing Months -0.02
Free Cash Flow Past Year -194,000
Free Cash Flow Prior Year 22,543,000

Options

Put/Call Ratio 0.02
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.19
MACD Signal -0.11
20-Day Bollinger Lower Band 1.86
20-Day Bollinger Middle Band 2.81
20-Day Bollinger Upper Band 3.75
Beta 0.74
RSI 23.90
50-Day SMA 3.69
150-Day SMA 7.21
200-Day SMA 10.46

System

Modified 11/25/2025 6:30:56 AM EST